2
Clinical Trials associated with Recombinant fimbrial adhesin dscCfaE vaccine(U S Army Medical Research & Development Command)A Phase 2b Controlled Efficacy Study of Intradermally Delivered ETEC Fimbrial Tip Adhesin Vaccine Against Experimental Challenge With ETEC H10407 in Healthy Adult Volunteers
The purpose of the study is to determine the efficacy of a vaccine against enterotoxigenic E. coli (ETEC)-caused diarrhea.
A Phase 1 Dose Escalating Study of Two Enterotoxigenic Escherichia Coli Prototype Adhesin-based Vaccines With or Without Modified Heat-labile Enterotoxin by Intradermal or Transcutaneous Immunization
The purpose of the study is to determine if immunization with a chimeric E. coli protein, dsc14CfaE-sCT2/LTB5, is safe and immunogenic when administered by vaccination under the skin.
100 Clinical Results associated with Recombinant fimbrial adhesin dscCfaE vaccine(U S Army Medical Research & Development Command)
100 Translational Medicine associated with Recombinant fimbrial adhesin dscCfaE vaccine(U S Army Medical Research & Development Command)
100 Patents (Medical) associated with Recombinant fimbrial adhesin dscCfaE vaccine(U S Army Medical Research & Development Command)
100 Deals associated with Recombinant fimbrial adhesin dscCfaE vaccine(U S Army Medical Research & Development Command)